Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$41.99 - $62.38 $720,968 - $1.07 Million
-17,170 Reduced 34.63%
32,408 $1.9 Million
Q3 2023

Oct 13, 2023

BUY
$27.8 - $45.35 $704,313 - $1.15 Million
25,335 Added 104.5%
49,578 $2.16 Million
Q2 2023

Jul 10, 2023

BUY
$36.13 - $49.49 $718,914 - $984,752
19,898 Added 457.95%
24,243 $876,000
Q1 2023

Apr 28, 2023

BUY
$36.54 - $54.26 $158,766 - $235,759
4,345 New
4,345 $162,000
Q3 2022

Oct 31, 2022

BUY
$59.5 - $86.7 $2.06 Million - $3 Million
34,637 Added 325.17%
45,289 $3.16 Million
Q2 2022

Jul 29, 2022

SELL
$39.16 - $88.71 $1.83 Million - $4.14 Million
-46,658 Reduced 81.41%
10,652 $715,000
Q1 2022

Apr 29, 2022

BUY
$75.82 - $150.97 $3.53 Million - $7.02 Million
46,511 Added 430.7%
57,310 $4.71 Million
Q4 2021

Feb 07, 2022

BUY
$132.01 - $190.29 $705,461 - $1.02 Million
5,344 Added 97.97%
10,799 $1.58 Million
Q3 2021

Nov 01, 2021

SELL
$132.13 - $177.45 $436,953 - $586,827
-3,307 Reduced 37.74%
5,455 $965,000
Q2 2021

Aug 12, 2021

SELL
$144.0 - $179.73 $765,648 - $955,624
-5,317 Reduced 37.77%
8,762 $1.42 Million
Q1 2021

May 13, 2021

BUY
$158.92 - $221.61 $1.95 Million - $2.73 Million
12,300 Added 691.4%
14,079 $2.41 Million
Q4 2020

Feb 04, 2021

SELL
$162.05 - $240.27 $1.02 Million - $1.52 Million
-6,318 Reduced 78.03%
1,779 $391,000
Q3 2020

Nov 09, 2020

SELL
$113.26 - $167.27 $1.77 Million - $2.61 Million
-15,610 Reduced 65.85%
8,097 $1.35 Million
Q2 2020

Jul 20, 2020

BUY
$72.01 - $120.39 $1.11 Million - $1.86 Million
15,445 Added 186.94%
23,707 $2.71 Million
Q1 2020

Apr 30, 2020

BUY
$69.78 - $116.21 $320,011 - $532,939
4,586 Added 124.76%
8,262 $635,000
Q4 2019

Jan 28, 2020

BUY
$70.76 - $128.86 $260,113 - $473,689
3,676 New
3,676 $474,000
Q3 2019

Nov 04, 2019

SELL
$77.91 - $109.6 $2.02 Million - $2.84 Million
-25,907 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$59.49 - $104.71 $1.29 Million - $2.27 Million
21,687 Added 513.91%
25,907 $2.67 Million
Q1 2019

Apr 29, 2019

SELL
$43.65 - $78.95 $763,089 - $1.38 Million
-17,482 Reduced 80.55%
4,220 $309,000
Q4 2018

Feb 01, 2019

BUY
$32.0 - $47.43 $694,464 - $1.03 Million
21,702 New
21,702 $921,000
Q1 2018

May 03, 2018

SELL
$17.2 - $34.95 $781,396 - $1.59 Million
-45,430 Closed
0 $0
Q4 2017

Jan 24, 2018

BUY
$12.65 - $19.0 $574,689 - $863,170
45,430
45,430 $829,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.